Augma Biomaterials is dedicated to the development, production, and marketing of synthetic bone substitutes for the dental market. The companys 3D Bond (biphasic calcium sulfate) functions as a scaffold for bone regeneration in dental procedures and is intended to fill, augment, or reconstruct bony defects in the oral and maxillofacial region. Augmas Bond Apatite combines 3D Bond with a formula of hydroxyapatite granules to create a cement-based osteoconductive composite. Bond Apatite is a synthetic bone substitute used for bone reconstruction in a range of dental applications and is intended for filling, augmenting, and reconstructing a wide variety of defects in the maxillofacial bones. The product is FDA cleared and CE approved.